|
|
Article: Artimplant Interim Report January - March 2009.
- Article from:
- Business Wire
- Article date:
- May 5, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
VASTRA FROLUNDA, Sweden -- Regulatory News:
Artimplant AB (STO:ARTIB):
* Net revenue for the first quarter amounted to SEK 4.8 million (2.1)* * The net loss for the first quarter totaled SEK 4.5 million (6.2) * Earnings per share for the first quarter amounted to SEK -0.08 (-0.10) * Sales of Artelon[R] Spacer totaled SEK 3.5 million (1.3) * Sales of Artelon[R] Tissue Reinforcement amounted to SEK 1.3 million (0.8) * Spacer agreements with Small Bone Innovations have been made non-exclusive and Artimplant's margin per unit sold has increased significantly
Events after the period-end * The Schulthess Clinic in Zurich has been granted clearance by ...